We are live on ! Find out more
NYLIM

New York Life Investment Management Portfolio holdings

AUM $14.3B
1-Year Est. Return 34.42%
This Fund
S&P 500
This Quarter Est. Return
+11.37%
1 Year Est. Return
+34.42%
3 Year Est. Return
+100.17%
5 Year Est. Return
+116.66%
10 Year Est. Return
+182.12%
AUM
$9.76B
AUM Growth
+$511M
Cap. Flow
-$384M
Cap. Flow %
-3.93%
Top 10 Hldgs %
25.08%
Holding
1,376
New
81
Increased
331
Reduced
895
Closed
63

Sector Composition

Rank Sector Weight
1 Technology 19.97%
2 Healthcare 8.88%
3 Financials 8.5%
4 Consumer Discretionary 7.96%
5 Industrials 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UMH
1301
UMH Properties
UMH
$1.39B
$156K ﹤0.01%
+10,197
New +$147K
JRVR icon
1302
James River Group Holdings
JRVR
$199M
$155K ﹤0.01%
16,789
-453
-3% -$5.2K
INGN icon
1303
Inogen
INGN
$154M
$153K ﹤0.01%
27,778
-752
-3% -$3.97K
VIR icon
1304
Vir Biotechnology
VIR
$1.52B
$150K ﹤0.01%
14,899
-401
-3% -$3.66K
EGIO
1305
DELISTED
Edgio, Inc. Common Stock
EGIO
$150K ﹤0.01%
10,914
-338
-3% -$8.34K
VCSA
1306
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$148K ﹤0.01%
18,016
-486
-3% -$3.94K
DHC
1307
Diversified Healthcare Trust
DHC
$2.02B
$144K ﹤0.01%
+38,373
New +$90.2K
TVTX icon
1308
Travere Therapeutics
TVTX
$5.86B
$137K ﹤0.01%
15,192
-639
-4% -$4.65K
TBRG
1309
DELISTED
TruBridge
TBRG
$127K ﹤0.01%
11,313
-477
-4% -$6.04K
XRN
1310
Chiron Real Estate Inc
XRN
$480M
$115K ﹤0.01%
+2,065
New +$100K
EBS icon
1311
Emergent Biosolutions
EBS
$233M
$79.2K ﹤0.01%
32,982
-1,385
-4% -$3.25K
SCLX icon
1312
Scilex Holding
SCLX
$48.5M
$69.6K ﹤0.01%
975
LCID icon
1313
Lucid Motors
LCID
$2.58B
$63.8K ﹤0.01%
1,515
-543
-26% -$24.4K
CIEN icon
1314
Ciena
CIEN
$61.2B
-16,489
Closed -$779K
CRWD icon
1315
CrowdStrike
CRWD
$226B
-14,028
Closed -$587K
DNA icon
1316
Ginkgo Bioworks
DNA
$486M
-530
Closed -$38.3K
DT icon
1317
Dynatrace
DT
$14.3B
-25,985
Closed -$1.21M
DXC icon
1318
DXC Technology
DXC
$1.71B
-28,728
Closed -$598K
EFIV icon
1319
State Street SPDR S&P 500 ESG ETF
EFIV
$1.04B
-33,840
Closed -$1.4M
EQH icon
1320
Equitable Holdings
EQH
$14.1B
-40,481
Closed -$1.15M
HTZ icon
1321
Hertz
HTZ
$998M
-14,537
Closed -$178K
HUN icon
1322
Huntsman Corp
HUN
$1.78B
-18,337
Closed -$447K
IJH icon
1323
iShares Core S&P Mid-Cap ETF
IJH
$128B
-206,850
Closed -$10.3M
JEF icon
1324
Jefferies Financial Group
JEF
$12.6B
-19,679
Closed -$721K
LYFT icon
1325
Lyft
LYFT
$6.28B
-10,547
Closed -$111K

Similar funds

New York Life Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, New York Life Investment Management held 1,376 positions worth $9.76B, up 5.5% from $9.25B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

New York Life Investment Management withdrew a net $384M in Q4 2023, closing 63 positions and reducing 895 holdings. Its most notable exit was IndexIQ ETF Trust IQ U.S. Large Cap ETF, an estimated $229M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

Against the trend, New York Life Investment Management opened a new position in NYLI CBRE NextGen Real Estate ETF worth $132M.

  • New York Life Investment Management's largest Q4 2023 buy was NYLI CBRE NextGen Real Estate ETF: 6,475,618 shares worth $132M.
  • New York Life Investment Management added most to iShares Core US Aggregate Bond ETF in Q4 2023, an estimated $21M increase.
  • New York Life Investment Management's biggest Q4 2023 reduction was NYLI MacKay Core Plus Bond ETF, cutting an estimated $19.8M.
  • New York Life Investment Management fully exited IndexIQ ETF Trust IQ U.S. Large Cap ETF in Q4 2023, selling an estimated $229M.
  • New York Life Investment Management's ten largest holdings make up 25% of its $9.76B portfolio in Q4 2023.
  • New York Life Investment Management opened 81 new positions and closed 63 in Q4 2023.
  • New York Life Investment Management's portfolio value rose 5.5% quarter-over-quarter to $9.76B.

Based on New York Life Investment Management's 13F filing for Q4 2023, filed 6 Feb 2024.